Edwards Lifesciences Corp (EW)vsNeuroone Medical Technologies Corp (NMTC)
EW
Edwards Lifesciences Corp
$85.76
+2.49%
HEALTHCARE · Cap: $49.36B
NMTC
Neuroone Medical Technologies Corp
$1.70
+3.03%
HEALTHCARE · Cap: $15.32M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 49453% more annual revenue ($6.30B vs $12.72M). EW leads profitability with a 17.4% profit margin vs -52.2%. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
NMTC
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.2%
Fair Value
$249.70
Current Price
$85.76
$163.94 discount
Intrinsic value data unavailable for NMTC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Safe zone — low bankruptcy risk
16.7% revenue growth
Revenue surging 72.5% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -123.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Altman Z-Score, Revenue Growth. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : NMTC
The strongest argument for NMTC centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 72.5% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.3x leaves little room for execution misses.
Bear Case : NMTC
The primary concerns for NMTC are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a growth stock while NMTC is a hypergrowth play — different risk/reward profiles.
EW carries more volatility with a beta of 0.85 — expect wider price swings.
NMTC is growing revenue faster at 72.5% — sustainability is the question.
NMTC generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 32/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Neuroone Medical Technologies Corp
HEALTHCARE · MEDICAL DEVICES · USA
NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?